Jemperli Injection contains dostarlimab, a prescription immunotherapy medicine used to treat certain types of cancer, particularly cancers with specific mismatch repair deficiency (dMMR) or microsatellite instability-high (MSI-H) characteristics.

Dostarlimab is a PD-1 inhibitor that works by helping the immune system recognize and attack cancer cells. Jemperli is administered by intravenous infusion under the supervision of an oncologist or qualified healthcare professional.

The Jemperli price, Jemperli injection price, Dostarlimab price, and Dostarlimab price in India may vary depending on the supplier, packaging, and availability. The recommended dose and treatment schedule depend on the patient’s condition and prescribed oncology regimen.

Product: Jemperli Injection
Active Ingredient: Dostarlimab
Form: Intravenous Infusion
Drug Class: PD-1 Inhibitor
Category: Prescription Cancer Immunotherapy